Respiratory Medicine
Volume 104, Issue 8 , Pages 1189-1196 , August 2010

Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions

  • Carlos A. Vaz Fragoso

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
    • Corresponding Author InformationCorresponding author. Internal Medicine, Clinical Epidemiology Research Center, VA Connecticut Healthcare System, Mailcode 151B, West Haven, CT 06516, USA. Tel.: +1 203 688 9423; fax: +1 203 688 4209.
    • ,
  • John Concato

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
    • ,
  • Gail McAvay

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • ,
  • Peter H. Van Ness

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • ,
  • Carolyn L. Rochester

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
    • ,
  • H. Klar Yaggi

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA
    • Veterans Affairs (VA) Clinical Epidemiology Research Center, West Haven, CT, USA
    • ,
  • Thomas M. Gill

      Affiliations

    • Yale University School of Medicine, Department of Internal Medicine, New Haven, CT, USA

Received 18 August 2009 ,Accepted 20 October 2009.

References 

  1. GOLD executive summary . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:532–555
  2. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968
  3. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ, Weinberger S, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2007;147:633–638
  4. Mannino DM, Doherty DE, Buist AS. Global initiative on obstructive lung disease (GOLD) classification of lung disease and mortality: findings from the atherosclerotic risk in communities (ARIC) study. Respir Med. 2006;100:115–122
  5. Hansen JF, Sun X-G, Wasserman K. Spirometric criteria for airway obstruction. Chest. 2007;131:349–355
  6. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med. 2008;177:253–260
  7. Meyer KC. Aging. Proc Am Thorac Soc. 2005;2:433–439
  8. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364:709–721
  9. Miller MR, Pincock AC. Predicted values: how should we use them?. Thorax. 1988;43:265–267
  10. Official Statement of the European Respiratory Society . Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests European community for steel and coal. Eur Respir J. 1993;6(S16):5–40
  11. Fragoso CAV, Concato J, McAvay G, Van Ness PH, Rochester CL, Yaggi HK, et al. Defining chronic obstructive pulmonary disease in older persons. Resp Med. 2009;103:1468–1476
  12. Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:1439–1450
  13. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300:2407–2416
  14. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review JAMA. 2002;288:1889–1897
  15. U.S. Department of Health and Human Services , National Center for Health Statistics . Third National Health and Nutrition Examination Survey, 1988–94, NHANES III Laboratory Data File (CD-ROM), Public Use Data File Documentation Number 76200. Hyattsville, MD: Centers for Disease Control and Prevention; 1996;Available from National Technical Information Service, Springfield, VA
  16. Wheatcroft G, Cox CS, Lochner KA. Comparative analysis of the NHANES III public-use and restricted-use linked mortality files. Hyattsville, MD: National Center for Health Statistics; 2007;http://www.cdc.gov/nchs/data/datalinkage/h3_mort_compare_2007_final.pdf
  17. American Thoracic Society . Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144:1202–1218
  18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
  19. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax. 2007;62:237–241
  20. Research Triangle Institute . SUDAAN Language Manual, Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2004;
  21. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503–1510
  22. Gross NJ. Chronic obstructive pulmonary disease outcome measurements. Proc Am Thorac Soc. 2005;2:267–271
  23. Cherry DK, Burt CW, Woodwell DA. National ambulatory medical care survey: 1999 summary. Adv Data Vital Health Stat (CDC). 2001;322:1–36
  24. Thomason MJ, Strachan DP. Which spirometric indices best predict subsequent death from chronic obstructive pulmonary disease?. Thorax. 2000;55:785–788
  25. Burrows B, Knudson RJ, Camilli AE, Lyle SK, Lebowitz MD. The "horse-racing effect" and predicting decline in forced expiratory volume in one second from screening spirometry. Am Rev Respir Dis. 1987;135:788–793
  26. Spirometry. http://www.ich.ucl.ac.uk/ich/academicunits/growinglungs/Homepage. Accessed April 24, 2009.
  27. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. NEJM. 2004;350:1005–1012
  28. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128:2640–2646
  29. Nishimura K, Tsukino M. Clinical course and prognosis of patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2000;6:127–132
  30. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality. Ann Intern Med. 2005;142:233–239
  31. Johannessen A, Omenaas , Bakke PS, Gulsvik A. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005;60:842–847
  32. Vestbo J, Hansen EF. Airway hyperresponsiveness and COPD mortality. Thorax. 2001;56(Suppl. 2):11–14
  33. Hansen EF, Vestbo J. Bronchodilator reversibility in COPD. Eur Respir J. 2005;26:6–7
  34. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Chest. 1999;116:603–613

PII: S0954-6111(10)00048-X

doi: 10.1016/j.rmed.2009.10.030

Respiratory Medicine
Volume 104, Issue 8 , Pages 1189-1196 , August 2010

Article Tools